新秀丽：美股双重上市细则披露，2位高管任命落地-20260225

Investment Rating - The report assigns a rating of "Accumulate" for the company [5]. Core Insights - The company has disclosed details regarding its dual listing in the US, aiming to enhance global trading liquidity. The recent appointments of the CFO and TUMI President are expected to positively impact performance, with Q4 2025 results anticipated to continue the improvement trend seen in Q3 [2][9]. - The company plans to issue American Depositary Shares (ADS) for its dual listing, with a maximum issuance limit of approximately 138 million shares, representing 9.97% of the total shares outstanding after excluding treasury shares. The funds raised will be used for operational and capital expenditures, debt repayment, share buybacks, and potential acquisitions [9][10]. - The report forecasts the company's net profit attributable to shareholders for 2025-2027 to be $268 million, $301 million, and $336 million, respectively, reflecting year-on-year changes of -22.3%, +12.2%, and +11.6%. A target price of HKD 24.09 is set based on a 15X PE for 2026 [9][12]. Financial Summary - The company's total revenue is projected to be $3,589 million in 2024, decreasing to $3,481 million in 2025, before increasing to $3,651 million in 2026 and $3,824 million in 2027. The gross profit is expected to follow a similar trend, with figures of $2,152 million, $2,074 million, $2,187 million, and $2,298 million for the respective years [4][12]. - The report indicates a decline in net profit for 2025, with a recovery expected in the following years, alongside improvements in profit margins due to anticipated market recovery in the Asia-Pacific and North American regions [9][10].